BlackRock, Inc. - Mar 31, 2025 Form SCHEDULE 13G/A Schedule Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: BIOCRYST PHARMACEUTICALS INC Common Stock
Symbol: BCRX
Shares outstanding: 208M shares
Disclosed Ownership: 17.5M shares
Ownership: 8.4%
Form type: SCHEDULE 13G/A
Date filed: 4/17/2025, 09:35 AM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	8.4%	17.5M	17.3M	0	Spencer Fleming	Managing Director